TEM Tempus AI, Inc.
$58.74
Tempus AI, Inc. (TEM) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran below TEM's own trailing one-year pace, with 83% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
9 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
9
106 transactions
Purchases
$0
0 shares
Sales
$84.7M
1,624,439 shares
Net activity
-$84.7M
purchases less sales
How much of that selling was preplanned? 83% planned / 17% discretionary
10b5-1 plan sales
$70.4M
94 transactions · 1,329,532 shares
Discretionary sales
$14.3M
12 transactions · 294,907 shares
Largest single sale: $6.6M.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| West Nadja | Director | Sell 10b5-1 | 3,000 | $69.00 | $207.0K | 31,981 −8.6% of holding | |
| LEFKOFSKY ERIC P 32 fills | CEO and Chairman | Sell 10b5-1 | 250,000 | $68.46 | $17.1M | 15,253,680 −1.6% of holding | |
| Fukushima Ryan | CEO, Data | Sell 10b5-1 | 14,286 | $70.00 | $1.0M | 47,420 −23.2% of holding | |
| Rogers James William | Chief Financial Officer | Sell 10b5-1 | 26,313 | $60.00 | $1.6M | 106,024 −19.9% of holding | |
| Schoenherr Thomas Edward 6 fills | CEO, Diagnostics | Sell 10b5-1 | 8,082 | $58.40 | $472.0K | 94,703 −7.9% of holding | |
| Polovin Andrew | EVP, Chief Legal Officer | Sell 10b5-1 | 7,927 | $56.00 | $443.9K | 138,140 −5.4% of holding | |
| LEFKOFSKY ERIC P | CEO and Chairman | Sell | 132,591 | $49.61 | $6.6M | 2,098,130 −5.9% of holding | |
| Fukushima Ryan | CEO, Data | Sell | 41,095 | $49.61 | $2.0M | 562,463 −6.8% of holding | |
| Rogers James William | Chief Financial Officer | Sell | 22,529 | $49.61 | $1.1M | 132,337 −14.5% of holding | |
| Polovin Andrew | EVP, Chief Legal Officer | Sell | 22,148 | $49.61 | $1.1M | 146,067 −13.2% of holding | |
| Schoenherr Thomas Edward | CEO, Diagnostics | Sell | 9,232 | $49.61 | $458.0K | 97,797 −8.6% of holding | |
| Bartolucci Ryan M | Chief Accounting Officer | Sell | 6,175 | $49.61 | $306.3K | 67,866 −8.3% of holding | |
| West Nadja | Director | Sell 10b5-1 | 3,000 | $53.90 | $161.7K | 34,981 −7.9% of holding | |
| Fukushima Ryan | CEO, Data | Sell 10b5-1 | 20,000 | $50.04 | $1.0M | 123,945 −13.9% of holding | |
| Fukushima Ryan 5 fills | CEO, Data | Sell 10b5-1 | 23,818 | $46.19 | $1.1M | 166,763 −12.5% of holding | |
| Epstein David R | Director | Sell 10b5-1 | 370 | $43.40 | $16.1K | 31,094 −1.2% of holding | |
| LEFKOFSKY ERIC P 12 fills | CEO and Chairman | Sell 10b5-1 | 250,000 | $42.06 | $10.5M | 15,342,403 −1.6% of holding | |
| Fukushima Ryan 4 fills | CEO, Data | Sell 10b5-1 | 33,284 | $57.39 | $1.9M | 187,063 −15.1% of holding | |
| Fukushima Ryan | CEO, Data | Sell 10b5-1 | 10,000 | $60.00 | $600.0K | 201,047 −4.7% of holding | |
| LEFKOFSKY ERIC P 10 fills | CEO and Chairman | Sell 10b5-1 | 166,250 | $57.48 | $9.6M | 15,514,198 −1.1% of holding | |
| Rogers James William | Chief Financial Officer | Sell 10b5-1 | 11,529 | $55.00 | $634.1K | 114,866 −9.1% of holding | |
| Doudna Jennifer A | Director | Sell 10b5-1 | 2,673 | $55.00 | $147.0K | 25,942 −9.3% of holding | |
| Epstein David R | Director | Sell 10b5-1 | 250 | $49.40 | $12.4K | 31,464 −0.8% of holding | |
| LEFKOFSKY ERIC P 4 fills | CEO and Chairman | Sell 10b5-1 | 166,250 | $46.70 | $7.8M | 15,620,748 −1.1% of holding | |
| LEFKOFSKY ERIC P | CEO and Chairman | Sell | 22,335 | $44.07 | $984.3K | 2,230,721 −1% of holding | |
| Fukushima Ryan | CEO, Data | Sell | 13,550 | $44.07 | $597.1K | 603,558 −2.2% of holding | |
| Rogers James William | Chief Financial Officer | Sell | 10,853 | $44.07 | $478.3K | 126,395 −7.9% of holding | |
| Polovin Andrew | EVP, Chief Legal Officer | Sell | 8,703 | $44.07 | $383.5K | 128,215 −6.4% of holding | |
| Bartolucci Ryan M | Chief Accounting Officer | Sell | 4,116 | $44.07 | $181.4K | 74,041 −5.3% of holding | |
| Schoenherr Thomas Edward | CEO, Diagnostics | Sell | 1,580 | $44.07 | $69.6K | 107,029 −1.5% of holding | |
| LEFKOFSKY ERIC P 4 fills | CEO and Chairman | Sell 10b5-1 | 166,250 | $51.13 | $8.5M | 15,684,039 −1% of holding | |
| LEFKOFSKY ERIC P 6 fills | CEO and Chairman | Sell 10b5-1 | 166,250 | $46.38 | $7.7M | 15,856,910 −1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.